RE:$0.51
Almost $8M market cap went up in smoke , so imagine how devastating a more costly cliniclal trial would have been.
Maybe Gagnon should forget about clinical trial and take the money to buy back shares.
He probably does not have the skills to manage growth based on new medical discoveries.